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Cancer symptom awareness and barriers to
symptomatic presentation in England—are
we clear on cancer?
M Niksic*,1, B Rachet2, F G Warburton1, J Wardle3, A J Ramirez1 and L J L Forbes1
1Promoting Early Cancer Presentation Group, King’s College London, Guy’s Hospital Campus, 42 Weston Street, London SE1
3QD, UK; 2Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine, Keppel Street, London
WC1E 7HT, UK and 3Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College
London, Gower Street, London WC1E 6BT, UK
Background: Low cancer awareness may contribute to delayed diagnosis and poor cancer survival. We aimed to quantify socio-
demographic differences in cancer symptom awareness and barriers to symptomatic presentation in the English population.
Methods: Using a uniquely large data set (n¼ 49 270), we examined the association of cancer symptom awareness and barriers to
presentation with age, gender, marital status and socio-economic position (SEP), using logistic regression models to control for
confounders.
Results: The youngest and oldest, the single and participants with the lowest SEP recognised the fewest cancer symptoms, and
reported most barriers to presentation. Recognition of nine common cancer symptoms was significantly lower, and
embarrassment, fear and difficulties in arranging transport to the doctor’s surgery were significantly more common in participants
living in the most deprived areas than in the most affluent areas. Women were significantly more likely than men to both recognise
common cancer symptoms and to report barriers. Women were much more likely compared with men to report that fear would
put them off from going to the doctor.
Conclusions: Large and robust socio-demographic differences in recognition of some cancer symptoms, and perception of some
barriers to presentation, highlight the need for targeted campaigns to encourage early presentation and improve cancer
outcomes.
Cancer survival in England is lower than in other high-income
Western countries (Coleman et al, 2011). About 6000 deaths per year
could be avoided if the 5-year cancer survival rate in England was the
same as the Western European average (Abdel-Rahman et al, 2009).
Breast, bowel and lung cancer accounted for approximately half of
these avoidable deaths. Late stage at diagnosis contributes to excess
deaths in England, along with the rest of the United Kingdom, from
breast (Møller et al, 2010), bowel (Maringe et al, 2013) and lung
cancer (Walters et al, 2013). A longer time interval from the onset of
symptoms to the first presentation to a doctor, often referred to as
prolonged ‘patient interval’, is likely to contribute to late stage at
diagnosis (Lyratzopoulos et al, 2012a).
People who do not recognise that unexplained symptoms may
be due to cancer are more likely to delay seeking medical help
(Macleod et al, 2009; Forbes et al, 2014). In a recent English study,
cancer patients who reported that they had not realised that their
symptoms were serious were twice as likely to have taken 43
months from first noticing a symptom to seeing a doctor, in
comparison with those who did not report this (Forbes et al, 2014).
In addition, people reporting more barriers to symptomatic
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presentation were more likely to say they would delay seeking
medical help (Robb et al, 2009; Simon et al, 2010).
In a recent population-based study, perceived barriers to
symptomatic presentation were more common in the United
Kingdom than in other high-income countries with similar health-
care systems (Forbes et al, 2013). For example, being ‘worried
about wasting the doctor’s time’ was perceived as a barrier to going
to the doctor with a symptom that might be serious by 34% of UK
participants, 21% of Canadians and only 9% of Swedes. Increased
barriers to presentation in the United Kingdom might contribute
to lower cancer survival, particularly if people lack awareness about
potential cancer symptoms.
Cancer symptom awareness is lower and barriers to sympto-
matic presentation are more commonly reported among people of
lower socio-economic position (SEP) (Brunswick et al, 2001; Robb
et al, 2009), and older people (Linsell et al, 2008). These may
contribute to the pattern of more advanced cancer at diagnosis and
lower cancer survival in these groups (Rachet et al, 2010;
Lyratzopoulos et al, 2012b). However, studies of cancer awareness
and barriers to presentation have included few people from the
oldest and most socio-economically disadvantaged groups (Robb
et al, 2009; Simon et al, 2010; Forbes et al, 2013). Therefore, these
studies lack power to comprehensively examine socio-demographic
differences in recognition of cancer symptoms and perception of
barriers in the population. In addition, few studies have used
validated measures (such as Robb et al, 2009; Simon et al, 2010).
Tailoring to the target population is critical to the success of
behavioural public health campaigns (NICE, 2007). We aimed to
quantify socio-demographic differences in cancer symptom
awareness and barriers to symptomatic presentation in the English
population, to inform the development of effective campaigns to
promote early presentation and to improve cancer survival.
MATERIALS AND METHODS
The data set included 18 cross-sectional surveys across England
that used the Cancer Research UK Cancer Awareness Measure
(CAM; Stubbings et al, 2009)—a validated measure of cancer
awareness—during 2009/2011. The surveys were coordinated by
the National Awareness and Early Diagnosis Initiative (NAEDI),
which encouraged local health bodies to measure cancer awareness
in their areas to inform commissioning of health services (Cancer
Research UK, 2011). Different health bodies used the CAM for a
variety of reasons, such as needs assessment or evaluation of local
campaigns to increase awareness. All surveys were conducted
before launching the first national campaigns in 2012 (Power and
Wardle, 2015). We excluded surveys that evaluated local cancer
awareness campaigns, such as the post-intervention survey in
Greater Manchester and Cheshire. Surveys were carried out in
urban and rural areas, in the North, South, West and East of
England (Supplementary Material 1). Participants in eight surveys
were recruited using random probability sampling from the
electoral roll, commercial telephone listings or the postal address
file, whereas 10 surveys used other types of sampling, such as
approaching people on the street or knocking door-to-door
(Supplementary Material 1).
Participants were interviewed using the CAM either face to face
(84%) or by telephone (16%). We analysed nine questions assessing
cancer symptom awareness and 10 questions assessing barriers to
presentation. Cancer symptom awareness was measured using the
question: ‘The following may or may not be warning signs of cancer.
We are interested in your opinion. Do you think X is a warning sign
for cancer?’ (Yes/No/Don’t know). Barriers to presentation were
assessed using the question: ‘Sometimes people put off going to see
the doctor, even when they have a symptom that they think might be
serious. These are some of the reasons people give for delaying.
Could you say if any of these might put you off going to the doctor?’
(Yes often/Yes sometimes/No/Don’t know).
Analysis. We added up ‘Yes’ responses to the questions about
cancer symptoms and analysed them as a cancer symptom
awareness score. Participants were considered to report a barrier
if their response was ‘Yes often’ or ‘Yes sometimes’ to questions
about barriers to presentation. We added up these responses to
generate a barriers score. We considered ‘No’ and ‘Don’t know’
responses as lack of awareness or lack of barriers. Descriptive
statistics were calculated for participants’ socio-demographic
characteristics (age groups, gender, marital status and SEP) in
relation to cancer awareness and barrier score. We estimated SEP
using an area-based measure, income domain of the indices of
multiple deprivation (IMD; Department for Communities and
Local Government, 2010), which we called ‘area income depriva-
tion’; and two individual level measures, educational attainment
(having a degree or not) and whether employed or not.
We assigned the income domain score of IMD to each participant
based on the area where they lived (Office of National Statistics,
2011). We then categorised participants according to quintiles of
the distribution of income domain of IMD in England in 2010. We
did not use the overall IMD score because it includes domains
reflecting access to health services and health disability, which may
be closely related to barriers to presentation.
We assessed whether cancer awareness or barriers score varied
between socio-demographic subgroups using Kruskal–Wallis tests.
We also examined the extent to which the socio-demographic
factors were associated with each other in order to understand
whether participants were equally distributed across socio-demo-
graphic subgroups. We examined the association between different
socio-demographic factors (independent variables) and both
recognition of individual cancer symptoms and perception of each
barrier to presentation (dependent variables), using logistic
regression models (Po0.001 level of significance). In the multi-
variable logistic regression model, we controlled for a priori
confounders; age group, gender and area income deprivation. In
sensitivity analyses, we repeated the multivariable logistic regres-
sion including only the surveys that used random probability
sampling to find out whether the results were affected by the
inclusion of studies with less robust sampling. We also compared
results of telephone and face-to-face interviews to assess whether
our conclusions would be different depending on the data
collection mode.
To identify the best approach in handling missing data, we
tested for systematic differences between the observed and missing
data. We found no clear patterns of missingness in relation to our
key variables—gender, age and area income deprivation. Nearly, all
participants (99.9%) had data on gender. Data were missing on age
group in surveys that had used non-standard age group
categorisations, which could not be aligned with those used in
the other surveys (5%). Participants with missing data on area
income deprivation (18%) mostly lived in particular areas, such as
North London, Merseyside and Cheshire, where participants’
postcodes, which are needed to assign area income deprivation,
had not been collected (Supplementary Material 2). In the
remaining surveys, the participants with missing postcodes
accounted for not 46% overall. Because of this relatively small
proportion of missing data, their impact on the estimates is likely
to be marginal. Overall, the missingness mechanism is very likely
to be missing completely at random (MCAR) for age, gender and
area income deprivation.
We used a complete-case analysis approach in which we
analysed data from participants with complete data on gender, age
group and area income deprivation. This approach—listwise
deletion of participants with missing data on covariates—is
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recommended where data are MCAR (Allison, 2002). It outper-
forms more sophisticated approaches, such as multiple imputation,
if there is no association between the probability of missing data
for both dependent and independent variables (Allison, 2002). The
sample size remained large (n¼ 38 630). All analyses were done
using Stata 12.1 (STATA Corp, 2012).
RESULTS
We collated data on 49 270 adult participants living in 94 Primary
Care Trust areas (PCTs) across England during 2009/2011
(Supplementary Material 2). At the time of the survey, PCTs were
the National Health Service (NHS) organisations responsible for
local health strategy, and commissioning and providing most
health services in England (n¼ 151 PCTs in total at the time). The
full sample (n¼ 49 270) and the sample used in our analyses
(n¼ 38 630) had similar socio-demographic characteristics
(Table 1). The gender and age distribution of our sample was
similar to that of the general population of England, where just
over half of the population was female; about a third was between
15 and 34 (32%), and between 35 and 54 (34%) years of age, 25%
was aged 55–74 years and 9% was aged 75þ years, according to
2010 population estimates (Office for National Statistics, 2012).
However, our sample was of lower SEP on average than the English
population as measured by income domain of IMD (Office of
National Statistics, 2011).
Age was associated with employment status, as 95% of the 75þ
-year-olds were retired, whereas B73% of the 35–54-year-olds
and 60% of the 15–34-year-olds were employed (Po0.0001). Most
single participants were aged 15–34 years (58%), most married
participants or those living with a partner (we will refer to this
group as ‘married’) were aged between 35 and 74 years (78%) and
most separated/divorced/widowed people (we will refer to this
group as ‘separated’) were aged between 55 and 74 years (80%;
Po0.0001). More separated and single participants lived in the
most deprived areas (37%, respectively) than those who were
married (30%; Po0.0001). More participants without a degree
lived in the most deprived areas (85%) than those who had
a degree (Po0.0001).
On average, participants recognised 7.2 out of 9 cancer
symptoms (Table 1), and o40% of them recognised all nine
cancer symptoms. Participants identified on average 1.8 barriers to
presentation out of a possible 10. About two-thirds of participants
(62%) identified at least one barrier to presentation, and
approximately a third of all participants (30%) reported three or
more barriers. There were significant differences between socio-
demographic groups in cancer awareness and barriers score,
although the mean number of reported barriers did not vary by
area income deprivation (Table 1).
Recognition of individual cancer symptoms. Participants most
frequently recognised ‘unexplained lump or swelling’ (94%), and
least frequently recognised ‘persistent cough or hoarseness’ and ‘sore
that does not heal’ (68%) as potential cancer symptoms (Figure 1).
Age group, gender, marital status, educational level, employ-
ment status and area income deprivation were all associated with
recognition of each cancer symptom in the multivariable logistic
Table 1. Socio-demographic characteristics of the full and complete-case sample, and recognition of cancer symptoms and
reported barriers to presentation in complete-case sample
Sample Full sample, n (%) Complete-case sample, n (%) Mean recognised symptoms (s.d.) Mean identified barriers (s.d.)
Total 49 270 (100) 38 630 (100) 7.2 (2.1) 1.8 (2.2)
Gender
Women 26987 (55) 21 606 (56) 7.4 (2.0)a 1.9 (2.2)a
Men 22225 (45) 17 024 (44) 7.0 (2.2) 1.7 (2.1)
Missing 58 (0)
Age (years)
15–34 12777 (26) 10 032 (26) 6.7 (2.3)a 2.3 (2.4)a
35–54 17571 (36) 14 280 (37) 7.3 (2.0) 1.9 (2.2)
55–74 13982 (28) 12 028 (31) 7.6 (1.8) 1.4 (1.9)
75þ 2506 (5) 2290 (6) 7.1 (2.2) 1.3 (1.8)
Missing 2434 (5)
Marital status
Married 21956 (44) 16 884 (44) 7.5 (1.9)a 1.7 (2.1)a
Single 10 168 (21) 7631 (20) 6.9 (2.3) 1.9 (2.4)
Separated 8262 (17) 6075 (16) 7.5 (1.9) 1.6 (2.0)
Missing 8884 (18) 8040 (21)
Education
With degree 9761 (20) 6932 (18) 7.7 (1.8)a 1.8 (2.0)a
Without degree 30015 (61) 23 661 (61) 7.3 (2.1) 1.7 (2.1)
Missing 9494 (19) 8037 (21)
Employment
Employed 20803 (42) 15 601 (40) 7.4 (2.0)a 1.9 (2.1)a
Not employed 9296 (19) 7211 (19) 6.9 (2.2) 2.0 (2.3)
Retired 10574 (22) 8051 (21) 7.6 (1.9) 1.2 (1.7)
Missing 8597 (18) 7767 (20)
Quintile of area income deprivation
1 (Least deprived) 4735 (10) 4595 (12) 7.6 (1.9)a 1.8 (2.0)
2 5661 (11) 5490 (14) 7.5 (1.9) 1.8 (2.1)
3 8424 (17) 8118 (21) 7.4 (2.0) 1.8 (2.2)
4 8733 (18) 8316 (22) 7.1 (2.2) 1.9 (2.1)
5 (Most deprived) 12 766 (26) 12 111 (31) 7.0 (2.2) 1.9 (2.2)
Missing 8951 (18)
Abbreviation: s.d.=standard deviation.
aDifference between groups significant at the Po0.0001 level (Kruskal–Wallis tests).
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regression analysis (Table 2). Women were more likely than men
to recognise each cancer symptom, except ‘persistent unexplained
pain’. We found the largest gender difference for recognition of
‘change in the appearance of a mole’. The odds of recognising this
symptom were 60% higher in women than men (OR¼ 1.60; 95%
confidence interval (CI): 1.46–1.75). Participants aged between 55
and 74 years were most likely to recognise each of the nine possible
symptoms of cancer. The youngest participants were least likely to
recognise six of the symptoms (unexplained bleeding, persistent
cough, changes in bowel/bladder habits, difficulty in swallowing,
sore that does not heal and unexplained weight loss). The oldest
participants were less likely than those aged 55–74 years to
recognise ‘unexplained lump or swelling’, ‘unexplained persistent
pain’ and ‘change in the appearance of a mole’. Participants who
were single were least likely to recognise all cancer symptoms.
We found a strong trend suggesting that the lower the SEP, the
less likely the participants were to recognise each cancer symptom.
Participants who were unemployed, the least educated and those
living in areas with highest area income deprivation were least
likely to recognise all cancer symptoms. The difference was most
marked for ‘change in appearance of a mole’. Participants living in
areas with the highest income deprivation had significantly lower
odds of recognising this symptom than those from the most
affluent areas (OR¼ 0.37; 95% CI: 0.31–0.45). In addition, the odds
of recognising ‘change in appearance of a mole’ as a potential
cancer symptom were B49–56% lower in participants without a
degree and the unemployed, respectively, in comparison with their
graduate or employed counterparts (OR¼ 0.67; 95% CI: 0.57–0.79;
and, OR¼ 0.64; 95% CI: 0.56–0.73, respectively). The results of the
unadjusted model were similar (Supplementary Material 3). The
sensitivity analysis to examine the effect of less robust survey
methods showed similar patterns, suggesting that the results were
unaffected by survey design. We also found no differences in
relation to the modes of interviewing—face-to-face and telephone
interviews produced similar results.
Barriers to symptomatic presentation. Approximately a third of
all participants (30%) reported that ‘worry about what the doctor
might find’ might put them off going to the doctor (Figure 2).
Participants were least likely to report that difficulties in arranging
transport to the doctor’s surgery would be a barrier to presentation
(6%).
Age group, gender, marital status, educational level, employ-
ment status and area income deprivation were all associated with
reporting each barrier to presentation in the multivariable models
(Table 3). Women were more likely than men to report each
barrier to presentation, except being ‘too busy’ to make time to go
to the doctor and difficult to ‘arrange transport’. Emotional
barriers, such as feeling ‘too scared’ or ‘too embarrassed’, ‘worry
about what the doctor might find’ and ‘not feeling confident
enough to talk about the symptoms’, were particularly common
among women. We found the largest gender difference for
reporting being ‘too scared’ to go to the doctor’s surgery—the
odds were 40% higher in women than men (OR¼ 1.40; 95%
CI: 1.31–1.50). All barriers to presentation, except transport
difficulties, decreased with age. The youngest participants most
frequently reported barriers to presentation compared with
55–74-year-old participants, especially being ‘too busy’
(OR¼ 3.07; 95% CI: 2.79–3.38). Arranging transport to the
doctor’s surgery was the only exception, which 75þ year-olds
were much more likely to report than 55–74-year-old participants
(OR¼ 2.30; 95% CI: 1.87–2.82).
Participants who were single most frequently reported barriers
to presentation, especially emotional barriers (feeling ‘too embar-
rassed’, ‘too scared’, ‘would not feel confident talking about my
symptoms’ and ‘worry about what the doctor might find’).
However, married participants more frequently reported that
being ‘too busy’ or ‘worried about many other things’ might put
them off going to the doctor than either separated or single
participants. Separated participants had B60% higher odds of
reporting that arranging transport to go to the doctor’s surgery
would be a barrier to presentation than married participants
(OR¼ 1.62; 95% CI: 1.36–1.93).
We found a trend suggesting that participants with lower SEP,
on both individual and area-based indicators, were more likely to
identify barriers to presentation. The trend was particularly strong
for emotional barriers. Participants of lower SEP hadB20% higher
odds of reporting that feeling ‘too embarrassed’ might prevent
them from going to the doctor than those of higher SEP (Table 3).
We found the largest difference for the barrier ‘it would be difficult
for me to arrange transport to the doctor’s surgery’ (graduate
Ch
an
ge
 in 
the
 ap
pe
ara
nc
e 
of 
a m
ole
%
 O
f p
ar
tic
ip
an
ts
 re
co
gn
isi
ng
 e
ac
h 
sy
m
pt
om
Un
exp
lain
ed
 lu
mp
/sw
elli
ng
Ch
an
ge
 in 
bo
we
l/bl
ad
de
r h
ab
its
Un
exp
lain
ed
 ble
ed
ing
Un
exp
lain
ed
 we
igh
t lo
ss
Pe
rs
iste
nt 
un
ex
pla
ine
d p
ain
Pe
rs
iste
nt 
dif
ficu
lty 
sw
allo
win
g
So
re 
tha
t d
oe
s n
ot 
he
al
Pe
rs
iste
nt 
co
ug
h/h
oa
rse
ne
ss
94
91
86 85
80 78
74
68 68
100
90
80
70
60
50
40
30
20
10
0
Figure 1. Frequency of recognition of cancer symptoms.
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vs non-graduate: OR¼ 1.34; 95% CI: 1.11–1.61; unemployed vs
employed: OR¼ 1.59; 95% CI: 1.34–1.89; and most deprived areas
vs least deprived: OR¼ 1.51; 95% CI: 1.27–1.88). Less educated
participants, the unemployed and those with the highest area
income deprivation were, however, less likely to report being ‘too
busy’ and ‘worry about many other things’. The results of the
unadjusted model were similar (Supplementary Material 4). The
sensitivity analysis suggested that the results were unaffected by
survey design. We also found no differences in relation to the
modes of interviewing—face-to-face and telephone interviews
produced similar results.
DISCUSSION
This study highlighted differences in the way that population
subgroups recognise cancer symptoms and their reasons to put off
going to the doctor. People with low SEP, the youngest and oldest,
and those who were single had the lowest cancer awareness, and
also found numerous reasons to deter them from seeking medical
help. Women had better awareness of cancer symptoms and
reported more barriers to help seeking than men.
Strengths and limitations. This is the first study to collate and
analyse a large data set on cancer awareness and barriers to
symptomatic presentation from local cross-sectional surveys across
England. To the best of our knowledge, this is the biggest
population-representative study of public cancer awareness. The
uniquely large sample allowed us to detect and quantify socio-
demographic differences in cancer awareness and barriers with
much higher statistical power and precision than any previous
study, assess a broader scope of socio-demographic factors, control
for potential confounders and conduct comprehensive sensitivity
analyses. We used a validated measure of cancer awareness,
adjusted our analyses for potential confounders and conducted
comprehensive sensitivity analyses. About a quarter of the
participants lived in the most deprived quintile of areas of
deprivation, a much larger number than in other studies. This
means we could provide more robust results in relation to the
underprivileged population, with better control for potential
confounders. This is the first study that allowed us to compare
the effect of both individual and area-based measures of SEP on
cancer symptom awareness and barriers to presentation. It has
been suggested to use both individual and area-based measures of
socio-economic status in surveys, because they may have different
or independent effects on health (Davey Smith et al, 1998).
Assessing only area-based measures of SEP can lead to poor
understanding of which individual characteristics contribute to
particular health outcomes, while assessing only individual
measures may lead to misunderstanding the role of wider
socio-economic context in health (Pickett and Pearl, 2001). The
fact that we observed similar effects using both individual and area-
based SEP measures made us more confident in our findings.
Possible limitations are that approximately half of the data were
collected in surveys that did not use random probability sampling,
which could have made the sample less representative. However,
when we repeated analyses using data collected from participants
selected by random probability sampling only, our results were
very similar. Some socio-demographic groups may have a greater
propensity to give ‘yes’ responses during interviews (acquiescence
bias) (Bowling, 2005). This is unlikely to fully explain the observed
results, as the groups who had more ‘yes’ responses in relation to
symptom awareness did not give more ‘yes’ responses in relation to
barriers. Some socio-demographic groups may have a greater
propensity to give ‘socially desirable’ answers in relation to some of
the questions about barriers, especially as most data were collected
using face-to-face interviews (Bowling, 2005). For example, being
‘too busy’ may be seen as more socially desirable among groups
with higher SEP or men (Sullivan, 2008). Potential social
desirability and interviewer bias were reduced by reassuring
participants of confidentiality and anonymity, and training the
interviewers to ensure they appear neutral during data collection.
Recognition of symptoms may have been somewhat overestimated,
because some participants could have guessed the correct answers
to the prompted questions (Robb et al, 2009).
Comparison of findings with previous literature. The youngest
age group had lower cancer symptom awareness than the middle-
aged group, which has been found in previous studies (Brunswick
et al, 2001; Robb et al, 2009). This is perhaps owing to their lower
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Figure 2. Frequency of reported barriers to symptomatic presentation.
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risk of being diagnosed with cancer, or because they are less likely
than older people to have the experience of cancer among peers or
relations. We also found that the oldest age group had lower
awareness of cancer symptoms than the middle-aged group.
Lumps, swellings and skin changes are common problems among
the elderly, and therefore might not be perceived as a serious health
threat (Bentley, 2003). Persistent pain is common among the over-
75 age group owing to conditions such as osteoarthritis, but is
underreported (Jakobsson and Hallberg, 2002). Older people may
believe that pain is an inevitable effect of the ageing process.
The oldest age group was least likely to report barriers to seeking
help, expect for difficulties in arranging transport to the doctor’s
surgery. This contrasts with the findings of a study in East London,
which found that women aged 65þ years were more likely to
report embarrassment, worry about wasting the doctor’s time, fear
and too many other things to worry about than younger women
(Forbes et al, 2010). This may reflect the inner city setting of that
study, which may not have been generalisable to all of England.
However, that study, similar to ours, found that older people were
more likely to have difficulty in arranging transport. Sensory and
physical impairments may prevent them from driving or using
public transport (Wagner et al, 2011), making them dependent on
others for transport needs.
Cancer awareness was higher in women than men. Health is
often perceived as a female domain, given that women have more
contact with health services, because of their reproductive role and
cultural expectations of caring for others. Previous studies reported
higher cancer awareness in women than men (Brunswick et al, 2001;
Robb et al, 2009). However, unlike other studies, we found no
gender differences in recognition of ‘unexplained, persistent pain’.
This is in line with a recent systematic review that found no evidence
that pain perception and pain sensitivity differ between men and
women (Racine et al, 2012), so once pain is experienced both
genders may attribute it to a potential health threat, such as cancer.
Women more frequently reported barriers to presentation,
especially fear and embarrassment. Robb et al (2009), on the other
hand, found no significant gender differences in reporting of
barriers, which may be because that study was smaller and lacked
power to show a statistically significant difference. Men may be
culturally less willing to admit that they experience some barriers,
in particular, embarrassment, fear or worry, perhaps perceiving
this to be emasculating (Evans et al, 2005). Men are less frequent
users of health services (Elliott et al, 2011), even after allowing for
more consultations for reproductive health issues in women
(Green and Pope, 1999), which suggests that they do indeed
experience barriers to symptomatic presentation. It is possible that
the CAM questionnaire does not measure those barriers that
particularly affect men.
Single participants were least likely to recognise cancer symptoms,
which is in agreement with previous findings (Brunswick et al, 2001;
Robb et al, 2009). Our novel finding was that this group was also
more likely to report barriers than married or separated participants.
A possible explanation is that partners may be more likely to notice
physical changes and encourage help seeking (Kaplan and Kronick,
2006). People with partners may be more likely to talk about their
symptoms with others, which may motivate them to seek help
(Burgess et al, 1998). Being single may also be a marker for low levels
of social support, which has been associated with patient delay in
presentation (Sundararajan et al, 2004).
Participants with lower SEP had a tendency to recognise fewer
cancer symptoms. Most previous studies reported this trend
(Brunswick et al, 2001; Robb et al, 2009), depending on which SEP
measures were used. Our study and Brunswick et al (2001) found
that having a degree or 415 years of full-time education
significantly increased cancer awareness, which was not reported
in the study by Robb et al (2009). Brunswick et al (2001) found no
significant differences in cancer awareness of unskilled workers
and those in professional or skilled manual occupations, although
there was a difference between unskilled and intermediate/small
employers. Robb et al (2009) observed highly significant
differences between all occupational groups. These inconsistencies
may be owing to lack of statistical power of the studies or potential
confounders, which have not been included in analyses. Our study
showed robust evidence that recognition of each symptom
gradually decreased with each quintile of area income deprivation,
which was significant after controlling for confounders. We also
showed that the unemployed had low cancer awareness, which
none of the previous studies assessed. The underprivileged tend to
have less health-protecting resources in their environment, such as
access to adequate nutrition or health services (Adler and Rehkopf,
2008). They may be more likely to interpret symptoms as ‘normal’
because of limited access to health information, linked with lack of
education (Brunswick et al, 2001) or due to their unhealthy lifestyle
(Dixon-Woods et al, 2006).
Participants with lower SEP reported increased worry about
what the doctor might find and embarrassment. Fear of cancer and
fatalistic beliefs about cancer prevention are common among
underprivileged people, especially those with low educational
attainment (Powe and Finnie, 2003). The underprivileged may
experience complex socio-cultural difficulties, such as feeling
intimidated by health-care professionals, or perceive social distance
owing to the difference in income and social status between
themselves and their doctor (Dixon-Woods et al, 2006). On the
other hand, participants with higher SEP most frequently reported
that being too busy or worrying about many other things might
prevent them from seeking medical help. Those with high career
aspirations may be under pressure to work long hours and more
readily accept additional work responsibilities, which may limit
their opportunities to engage in health preventive behaviour.
However, it may also be part of the professional narrative of high
status groups who are ‘Income Rich, Time Poor’ and subjective
experience of ‘busyness’, which is commonly associated with status
distinction and affluence (Sullivan, 2008).
Implications. A guiding principle of the NHS Cancer Plan
(Department of Health, 2000), and every subsequent national
strategy for cancer, is that early cancer detection and diagnosis
saves lives, because treatments are most likely to be effective in
people who are diagnosed at an earlier stage. Public health
campaigns, aimed at encouraging early presentation and down-
staging cancer, could be more targeted to specific population
groups and tailored according to their needs. Our study provided
the most robust evidence on socio-demographic differences in
cancer awareness and barriers to help seeking, required to improve
targeting of these campaigns. More specifically, men might benefit
more from educational campaigns aimed at increasing their
awareness of cancer symptoms. Psychological campaigns aimed
at alleviating cancer-related fears and embarrassment in relation to
seeking help may be more beneficial for women. Policy to promote
earlier symptomatic presentation should also include strategies to
promote confidence to discuss potential symptoms, and allay
embarrassment among the underprivileged and people with low
levels of social support. We need to ensure that these groups, and
older people, have appropriate and affordable transport options to
reach health services. While it is important to ensure that younger
people are equipped with the knowledge and skills to seek help
promptly, encouraging health service use among those at lowest
risk of cancer may raise anxiety levels and increase burden on
health services at the expense of those at higher risk.
Our study suggests that different socio-demographic groups
have different levels of cognitive and attitudinal readiness to seek
medical help, which need to be addressed to tackle inequalities in
access to services. This is in line with the Department of Health’s
Improving Outcomes: A Strategy for Cancer, which aims to reduce
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inequalities in cancer services and outcomes by promoting early
diagnosis and optimal treatments among the underprivileged
(Department of Health, 2011). However, tackling the problem of
health inequalities requires more complex solutions that go beyond
simply increasing access to services. In countries with universal
health-care system, such as England, access is free at the point of
service, but this does not mean that all groups can use services with
equal ease (Dixon-Woods et al, 2006). People with low SEP may
lack the skills necessary to negotiate their ways to use the health
services (Dixon-Woods et al, 2006). Therefore, going to poor
communities to raise their cancer awareness and reassuring people
that early detection saves lives may be a better way for health-care
professionals to reach the underprivileged. Another approach is to
use narratives of cancer survivors from poor communities in
adverts, promoting early presentation. This may be more helpful
than using images of doctors listing the possible symptoms of
cancer, which might be difficult to relate to.
The ‘Be Clear on Cancer’ campaigns, launched in England in
2010, aim to promote earlier diagnosis and increase public
awareness of symptoms of different types of cancer (Cancer
Research UK, 2011). There have been promising early results. The
first national lung campaign suggested better recognition of
persistent cough as an early cancer symptom, along with a shift
towards an early-stage distribution of non-small cell lung cancer,
and increase in surgical resection rate for patients diagnosed during
the campaign in comparison with the same period the previous year
(Ironmonger et al, 2014). High media coverage of breast cancer in
comparison with other most common cancers (Konfortion et al,
2014) could explain why over 90% of our participants recognised an
unexplained lump as a possible symptom. Other types of cancer
require more media attention and targeted campaigns to help people
recognise the early symptoms more effectively.
Future research should explore whether cancer symptom
awareness is directly or indirectly associated with cancer survival,
and what are the underlying mechanisms of this interaction. It is
possible that the mechanism could be delayed presentation, which
could contribute to advanced-stage diagnosis and poor cancer
survival. This hypothesis has been tested in the ongoing NAEDI
research projects (Cancer Research UK, 2011). Our study
quantified the socio-demographic differences in cancer awareness
and barriers to presentation, and suggested how to use these to
better target heath campaigns. However, future studies should pilot
the targeted campaigns and determine whether they are cost-
effective before implementing them nationally. Finally, under-
standing the reasons why people in our sample identified certain
barriers, for example, why people worry about wasting the doctor’s
time, could further improve the effectiveness of future campaigns.
Our findings could contribute to improving cancer survival in
England to match the best in Europe by helping to develop targeted
campaigns promoting early presentation of cancer symptoms.
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